Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).

This multicenter, randomized phase 2 trial compared neoadjuvant camrelizumab plus chemotherapy (ICT) versus chemoradioth...

Continue ReadingCamrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).

Quality Indicators for Screening and Surveillance of Colorectal Cancer in Adults: A Review of Performance Measures by the American College of Physicians.

Colorectal cancer is a leading cause of cancer-related deaths, and screening effectively reduces morbidity and mortality...

Continue ReadingQuality Indicators for Screening and Surveillance of Colorectal Cancer in Adults: A Review of Performance Measures by the American College of Physicians.